Global X MSCI China Health Care ETF (CHIH)
| Assets | $8.71M |
| Expense Ratio | 0.65% |
| PE Ratio | 16.25 |
| Shares Out | n/a |
| Dividend (ttm) | $0.07 |
| Dividend Yield | 0.53% |
| Ex-Dividend Date | Dec 28, 2023 |
| Payout Ratio | 8.63% |
| 1-Year Return | -17.95% |
| Volume | 204 |
| Open | 13.85 |
| Previous Close | 13.61 |
| Day's Range | 13.85 - 13.85 |
| 52-Week Low | 13.02 |
| 52-Week High | 20.00 |
| Beta | n/a |
| Holdings | 81 |
| Inception Date | Dec 7, 2018 |
About CHIH
Fund Home PageThe Global X MSCI China Health Care ETF (CHIH) is an exchange-traded fund that is based on the MSCI China Health Care 10-50 index. The fund tracks a market cap-weighted index of Chinese large- and mid-cap companies in the health care sector. The index includes A shares. CHIH was launched on Dec 7, 2018 and is issued by Global X.
Top 10 Holdings
48.14% of assets| Name | Symbol | Weight |
|---|---|---|
| BeiGene Ltd Ordinary Shares | BEIGF | 8.21% |
| CSPC Pharmaceutical Group Ltd | 1093.HK | 7.73% |
| WuXi Biologics (Cayman) Inc | 2269.HK | 5.72% |
| Innovent Biologics Inc | 1801.HK | 5.62% |
| Sino Biopharmaceutical Ltd | 1177.HK | 4.23% |
| Legend Biotech Corporation | LEGN | 3.66% |
| Wuxi AppTec Co Ltd | WUXIF | 3.63% |
| Sinopharm Group Co Ltd | 1099.HK | 3.35% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | 300760.SZ | 3.01% |
| Genscript Biotech Corp Class H | 1548.HK | 2.96% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 28, 2023 | $0.02825 | Jan 8, 2024 |
| Jun 29, 2023 | $0.0453 | Jul 10, 2023 |
| Dec 29, 2022 | $0.04557 | Jan 9, 2023 |
| Jun 29, 2022 | $0.02341 | Jul 8, 2022 |
| Dec 30, 2020 | $0.01713 | Jan 8, 2021 |
| Dec 30, 2019 | $0.109 | Jan 8, 2020 |
News
Institutional Investor Eyes Opportunity in Tech and Healthcare in China
Institutional money appears ready to come back to China again after a tumultuous 2021 that saw the Evergrande Crisis and heavy regulations on the tech industry. As such, here are a pair of Global X ET...
China ETFs Drop On Audit Enforcement
The first tranche of Chinese ADRs affected by a 2020 law has been released.
How to Invest in a Breakout Healthcare Industry in China
The China healthcare industry is expected to experience exponential growth, putting the focus on exchange traded funds (ETFs) like the Global X MSCI China Health Care ETF (CHIH), which is up 20% YTD. ...
Healthcare Is Lucrative in the States. Investors Shouldn't Stop There
When it comes to healthcare stocks and ETFs, investors typically home in on domestic fare, but the Global X MSCI China Health Care ETF (CHIH) is proving that it can be rewarding to consider the intern...
Healthcare. China. This Global X ETF Combines Two Potent Sectors
Healthcare came to the forefront during the height of the Covid-19 pandemic, but that doesn't mean interest in the sector is waning. ETF investors looking for opportunities in healthcare with internat...
An ETF to Get In On Chinese Healthcare's Banner Year
In the U.S., the healthcare sector was one of the strong performers amid the height of the COVID-19 pandemic. The same can be said for China.
An Unusual Healthcare ETF Is Impressing This Year
When it comes to healthcare stocks and ETFs, investors typically hone in on domestic fare, bu the Global X MSCI China Health Care ETF (CHIH) is proving that it can be rewarding to consider the interna...
Best Pharmaceutical ETFs for Q1 2020
The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.
China Coronavirus Outbreak Weighs on Stock, but Lifts Healthcare Names
Chinese stocks retreated Tuesday on news that six people have died and 291 have been infected there by a new coronavirus. However, some ETFs with exposure to Chinese healthcare stocks, including the G...